MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1089/cap.2010.0084

Медицинская библиотека · Journal of child and adolescent psychopharmacology · 2011

Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder.

Findling Robert L, Kafantaris Vivian, Pavuluri Mani, McNamara Nora K, McClellan Jon, Frazier Jean A, Sikich Linmarie, Kowatch Robert, Lingler Jacqui, Faber Jon, Rowles Brieana M, Clemons Traci E, Taylor-Zapata Perdita

Сравнительное исследованиеСтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

OBJECTIVE

The primary goal of this exploratory study was to obtain data that could lead to evidence-based dosing strategies for lithium in children and adolescents suffering from bipolar I disorder.

METHODS

Outpatients aged 7-17 years meeting Diagnostic and Statistical Manual of Mental Disorders, 4th edition, diagnostic criteria for bipolar I disorder (manic or mixed) were eligible for 8 weeks of open label treatment with lithium in one of three dosing arms. In Arm I, participants began treatment at a dose of 300 mg of lithium twice daily. The starting dose of lithium in Arms II and III was 300 mg thrice daily. Patients in Arms I and II could have their dose increased by 300 mg/day, depending on clinical response, at weekly visits. Patients in Arm III also had mid-week telephone interviews after which they could also have their dose of lithium increased by 300 mg per day. Youths weighing <30 kg were automatically assigned to Arm I, whereas youths weighing ≥30 kg were randomly assigned to Arm I, II, or III. Randomization was balanced by age (7-11 years, 12-17 years) and sex in approximately equal numbers. A priori response criteria were defined as a Clinical Global Impressions-Improvement scale score of ≤ 2 and a 50% decrease from baseline on the Young Mania Rating Scale.

RESULTS

Of the 61 youths [32 males (52.5%)] who received open-label lithium, 60 youths completed at least 1 week of treatment and returned for a postbaseline assessment. Most patients had a ≥ 50% improvement in Young Mania Rating Scale score, and more than half of the patients (58%) achieved response. Overall, lithium was well tolerated. All three treatment arms had similar effectiveness, side effect profiles, and tolerability of lithium.

CONCLUSIONS

On the basis of these results, a dosing strategy in which pediatric patients begin lithium at a dose of 300 mg thrice daily (with an additional 300 mg increase during the first week), followed by 300 mg weekly increases until a priori stopping criteria are met, will be used in an upcoming randomized, placebo-controlled trial.

Для цитирования: Findling Robert L, Kafantaris Vivian, Pavuluri Mani, McNamara Nora K, McClellan Jon, Frazier Jean A, Sikich Linmarie, Kowatch Robert, Lingler Jacqui, Faber Jon, Rowles Brieana M, Clemons Traci E, Taylor-Zapata Perdita. Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder.. Journal of child and adolescent psychopharmacology. 2011. DOI: 10.1089/cap.2010.0084.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.